Demant
Demant A/S, commonly known as Demant, is a leading global player in the hearing healthcare and personal communication industry, headquartered in Denmark (DK). Founded in 1904, the company has evolved significantly, marking key milestones such as the introduction of innovative hearing aids and advanced audiometric equipment. Demant operates extensively across Europe, North America, and Asia, focusing on hearing aids, audiometric instruments, and personal communication solutions. Their core products, renowned for their cutting-edge technology and user-centric design, set them apart in a competitive market. With a strong commitment to research and development, Demant has established itself as a trusted name, achieving notable recognition for its contributions to improving the quality of life for individuals with hearing loss.
DitchCarbon Score
How does Demant's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Demant's score of 38 is higher than 98% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Demant's reported carbon emissions
In 2023, Demant reported total greenhouse gas emissions of approximately 793,306,000 kg CO2e, with emissions distributed across various scopes: 14,973,000 kg CO2e from Scope 1, 15,496,000 kg CO2e from Scope 2, and 793,306,000 kg CO2e from Scope 3. This reflects a significant commitment to addressing climate change, as the company has set ambitious targets to reduce its carbon footprint. Demant aims to achieve net-zero greenhouse gas emissions across its entire value chain by 2050, using 2019 as the baseline year. The company has established near-term targets to reduce absolute Scope 1 and 2 emissions by 46.2% and Scope 3 emissions by the same percentage by 2030. Furthermore, long-term goals include a 90% reduction in both Scope 1 and 2 emissions and Scope 3 emissions by 2050. These targets align with the Science Based Targets initiative (SBTi) and demonstrate Demant's commitment to sustainable practices within the healthcare technology sector. The company's proactive approach to reducing emissions underscores its dedication to environmental responsibility and climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | 14,973,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 14,973,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 14,973,000 | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Demant is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
